1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures
(
- Contribution to journal › Article
-
Mark
Gray and white matter imaging : A biomarker for cognitive impairment in early Parkinson's disease?
(
- Contribution to journal › Article
- 2015
-
Mark
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
The role of the amygdala during emotional processing in Huntington's disease : from pre-manifest to late stage disease
(
- Contribution to journal › Article
-
Mark
Retrospective assessment of movement disorder society criteria for mild cognitive impairment in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Improving response inhibition in Parkinson's disease with atomoxetine
(
- Contribution to journal › Article
- 2014
-
Mark
Which patients with Parkinson's disease participate in clinical trials? : One centre's experiences with a new cell based therapy trial (TRANSEURO)
(
- Contribution to journal › Article
-
Mark
Mild cognitive impairment and Parkinson's disease - something to remember
(
- Contribution to journal › Article
-
Mark
Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Targeting impulsivity in Parkinson's disease using atomoxetine
(
- Contribution to journal › Article